Home VTE treatment with rivaroxaban safe and effectiveJuly 22, 2015CardiologyThrombosisPulmonologyHematology
Dicloxacillin may cut INR levels in warfarin usersJuly 21, 2015ThrombosisCardiologyPulmonologyInfectious DiseasesHematology
Bivalirudin in STEMI has low real-world stent thrombosis rateJuly 14, 2015ThrombosisCardiologyHematology
Routine screening sufficient for detecting occult cancer in patients with VTEJuly 13, 2015PulmonologyThrombosisCardiologyHematology
In PCI, switching clopidogrel nonresponders to prasugrel halved 2-year cardiac mortalityJuly 12, 2015ThrombosisCardiologyHematology
Risk of major bleeding is decreased when AF patients do not receive bridging anticoagulationJuly 10, 2015Perioperative MedicineThrombosisHematology
High VTE recurrence risk persists for at least 3 yearsJuly 9, 2015ThrombosisPulmonologyCardiologyHematology
Statins showed no benefit in reducing risk of recurrent VTEJuly 9, 2015ThrombosisPulmonologyCardiologyHematology
Extended warfarin delays return of unprovoked pulmonary embolismJuly 7, 2015PulmonologyThrombosisCardiologyHematology
Study establishes protocol for perioperative dabigatran discontinuationJune 25, 2015CardiologyNeurologyHematology
Idarucizumab reverses dabigatran’s anticoagulant effectsJune 24, 2015ThrombosisCardiologyTraumaHematologyPerioperative Medicine
‘Modest’ uptake of novel anticoagulants in real-world practiceJune 9, 2015CardiologyHematologyThrombosis
IHC: IV dihydroergotamine linked to increased thrombosis riskJune 7, 2015ThrombosisNeurologyHematologyCardiology
Warfarin bridge therapy ups bleeding risk, with no reduction in VTEMay 26, 2015PulmonologyCardiologyHematologyPerioperative MedicineThrombosis
